Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 281 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 2,127.0 | $398K | 0.09% | -1K | -38.4% | $187.28 | +9.4% |
| 282 | ANNX | ANNEXON INC | Healthcare | 69,468.0 | $397K | 0.09% | +15K | +26.6% | $5.71 | -31.3% |
| 283 | SGP | SPYGLASS PHARMA INC | Healthcare | 17,744.0 | $395K | 0.09% | NEW | — | $22.26 | +30.1% |
| 284 | BBDC | BARINGS BDC INC | Financial Services | 46,262.0 | $394K | 0.09% | -10K | -17.4% | $8.52 | +2.5% |
| 285 | ANAB | ANAPTYSBIO INC | Healthcare | 5,835.0 | $394K | 0.09% | -232.0 | -3.8% | $67.50 | -19.0% |
| 286 | CADL | CANDEL THERAPEUTICS INC | Healthcare | 38,224.0 | $394K | 0.09% | NEW | — | $10.30 | +8.0% |
| 287 | — | ASSEMBLY BIOSCIENCES INC | — | 14,251.0 | $392K | 0.09% | +7K | +88.7% | $27.48 | — |
| 288 | FCT | FIRST TR SR FLTG RATE INCOME | Financial Services | 40,444.0 | $391K | 0.09% | -11K | -21.5% | $9.66 | +0.1% |
| 289 | EVF | EATON VANCE SR INCOME TR | Financial Services | 78,410.0 | $390K | 0.09% | -20K | -20.7% | $4.98 | -2.2% |
| 290 | CGON | CG ONCOLOGY INC | Healthcare | 5,493.0 | $390K | 0.09% | -1K | -17.5% | $71.05 | +2.1% |
| 291 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 57,303.0 | $390K | 0.09% | +10K | +21.7% | $6.81 | -25.7% |
| 292 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 10,464.0 | $389K | 0.09% | +553.0 | +5.6% | $37.21 | +3.5% |
| 293 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 3,987.0 | $389K | 0.09% | -2K | -38.4% | $97.48 | +7.5% |
| 294 | PRTA | PROTHENA CORP PLC | Healthcare | 39,660.0 | $388K | 0.09% | +13K | +50.7% | $9.79 | -14.9% |
| 295 | GLAD | GLADSTONE CAP CORP | Financial Services | 19,977.0 | $388K | 0.09% | -8K | -29.7% | $19.42 | +0.0% |
| 296 | DSU | BLACKROCK DEBT STRATEGIES FD | Financial Services | 39,931.0 | $387K | 0.09% | -12K | -22.5% | $9.70 | -6.3% |
| 297 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 38,002.0 | $387K | 0.09% | -3K | -6.8% | $10.19 | +2.5% |
| 298 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 12,123.0 | $387K | 0.09% | +74.0 | +0.6% | $31.94 | -20.4% |
| 299 | — | ACHIEVE LIFE SCIENCE INC | — | 59,275.0 | $387K | 0.09% | NEW | — | $6.53 | — |
| 300 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 11,272.0 | $387K | 0.09% | +1K | +13.1% | $34.32 | -32.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.2%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%